Home
/
NowPatient Blog
/
What is asbestosis?

What is asbestosis?

Navin Khosla NowPatientGreen tick
Created on 16 Jul 2024
Updated on 16 Jul 2024

Asbestosis is a serious and debilitating lung condition that has plagued individuals for decades, particularly those who have been exposed to asbestos fibres in the workplace. This disease is caused by the inhalation of microscopic minerals, leading to a range of respiratory complications and even life-threatening consequences. Let’s look into the details of asbestosis to gain a clearer understanding of this condition.

What is asbestos?

Asbestos is a group of naturally occurring mineral fibres that have been widely used in various industries due to their remarkable heat and chemical resistance, as well as their low cost. These fibres, when released into the air, can be inhaled, leading to the development of asbestosis. The two main types of asbestos fibers are serpentine and amphibole, with the latter being more toxic and posing a greater threat to human health.

Asbestos exposure

Asbestos exposure can occur in a variety of settings, with the most common being in work environments. Workers in industries such as construction, mining, shipyards, and manufacturing have faced the highest risk of asbestos exposure in the past. However, bystander exposure, where individuals are exposed to asbestos fibers brought home on the clothing or skin of workers, and general community exposure, such as through the use of asbestos-containing materials in infrastructure, are also significant contributors to the asbestosis epidemic.

Six varieties of asbestos

Asbestos is a group of six distinct fibrous minerals, each with its own unique characteristics and implications. These six types of asbestos are:

Tremolite asbestos

Tremolite asbestos, though not commonly used in industrial or commercial applications, can be found in certain talcum powders and other products. Inhalation of tremolite fibres can be severely damaging to the lungs, making it a concern for those who may be exposed to it.

Actinolite asbestos

Actinolite asbestos was not widely used in industrial or commercial settings. However, the airborne actinolite fibres are easily inhaled and can cause significant harm to the respiratory system.

Anthophyllite asbestos

Like tremolite and actinolite, anthophyllite asbestos was not used extensively in industrial or commercial applications. Nonetheless, it could occasionally be found in certain vermiculite products, posing a potential risk to those who may come into contact with it.

Chrysotile asbestos

Also known as white asbestos, chrysotile asbestos is unique in its serpentine fibre-formation, which is distinct from the amphibole fibre-formation of the other asbestos types. Chrysotile asbestos is less likely to be inhaled than the other varieties, making it the “safest” of the asbestos types. However, all forms of asbestos, including chrysotile, are hazardous and can lead to serious health consequences.

Amosite asbestos

Also referred to as Grunerite or brown asbestos, amosite asbestos is an amphibole variety that originated in Africa. It was widely used in various industrial applications, such as cement sheet and pipe insulation, due to its durability and fire-resistant properties.

Crocidolite asbestos

Crocidolite (blue) asbestos, is an amphibole mineral found primarily in Africa and Australia. It is considered the most dangerous type of asbestos, as it is more likely to be inhaled and can cause severe health problems, including mesothelioma, a rare and aggressive form of cancer.

The nature of asbestosis

One of the most dangerous aspects of asbestosis is its hidden nature. Like other asbestos-related diseases, it can take anywhere from 20 to 30 years for the symptoms of the disease to show up. This makes it challenging to establish a clear link between exposure and the development of the condition. Asbestos fibers can remain in the lungs for a long period before the disease develops. This long period further complicates the diagnosis and management of asbestosis, as individuals may not be aware of their exposure until the disease has already progressed.

The gradual phasing out of asbestos

Asbestos was widely used in building materials, insulation, brake pads, and a myriad of household products. However, as the health risks associated with asbestos exposure became more apparent, there has been a gradual phasing out of its use in many countries.

In the United Kingdom, the importation of blue (crocidolite) and brown (amosite) asbestos was banned in 1985, and was extended to include white (chrysotile) asbestos in 1999. This reflects the growing awareness and concern surrounding the hazards posed by asbestos and the need to prioritise public health and safety.

Symptoms of asbestosis

Symptoms of asbestosis are characterised by a range of respiratory symptoms that typically develop gradually over time. Understanding the classic signs and symptoms of this condition is crucial for early diagnosis and effective management.

Respiratory symptoms

The main symptom of asbestosis is shortness of breath, particularly during physical exertion. Patients may also experience a persistent, non-productive cough, as well as chest discomfort or tightness. In more advanced stages, individuals may develop wheezing and extreme tiredness, further compromising their quality of life.

Physical examination findings

Physical examination of individuals with asbestosis may reveal the presence of bibasilar crackles, a distinctive crackling sound heard during lung auscultation. Additionally, some patients may exhibit clubbing of the fingertips, a condition characterised by the thickening and rounding of the nails, which can be a sign of underlying lung disease.

Radiographic findings

Imaging studies, such as chest X-rays and high-resolution computed tomography (HRCT) scans, play a crucial role in the diagnosis of asbestosis. These imaging tests can detect the characteristic patterns associated with the disease, including diffuse reticulonodular infiltrates, pleural thickening, and calcified pleural plaques.

Diagnosis and evaluation of asbestosis

Diagnosing asbestosis requires combining a thorough medical history, physical examination, and various diagnostic tests. Accurately identifying this condition is essential for guiding treatment and management strategies.

Occupational history and exposure assessment

A detailed occupational history is a critical component of the diagnostic process for asbestosis. Healthcare providers must carefully inquire about the patient’s past and present work environments, as well as any potential exposures to asbestos-containing materials. This can help establish the likelihood of asbestos exposure and support the diagnosis of asbestosis.

Lung function tests

Lung function tests, such as spirometry and diffusion capacity measurements, are essential to work out the damage to the lungs. These tests can reveal the severity of lung impairment.

Imaging

As mentioned earlier, chest imaging plays a crucial role in the diagnosis of asbestosis. Chest X-rays and HRCT scans can detect the characteristic radiographic findings, including interstitial fibrosis, pleural thickening, and calcified pleural plaques. In some cases, a lung biopsy may be necessary to confirm the diagnosis and rule out other interstitial lung diseases.

Biomarkers tests

Certain lab tests, such as the measurement of inflammatory markers like C-reactive protein and antinuclear antibodies, can provide support for the diagnosis of asbestosis. These biomarkers may help differentiate asbestosis from other interstitial lung diseases with similar clinical presentations.

Treatment and management of asbestosis

Unfortunately, there is no cure for asbestosis, as the damage to the lungs caused by asbestos exposure is irreversible. However, a multifaceted approach to treatment and management can help alleviate symptoms, slow disease progression, and improve the overall quality of life for individuals living with this condition.

Pharmacological interventions

Corticosteroids and other anti-inflammatory medications have been explored as potential treatments for asbestosis, aiming to suppress the ongoing inflammatory process and reduce further lung damage. However, the efficacy of these therapies remains limited, and their role in the management of asbestosis is still a subject of debate.

Supportive care and oxygen therapy

Supportive care is a crucial aspect of managing asbestosis. This may include using supplemental oxygen to improve oxygenation and alleviate breathlessness, as well as pulmonary rehabilitation programs that include exercise, education, and breathing techniques to enhance functional capacity and quality of life.

Surgical interventions

In some cases, surgical interventions may be considered for the management of asbestosis-related complications. Decortication, which involves the removal of the thickened pleural tissue, and lung transplantation in severe, end-stage cases, may be explored as treatment options.

Preventive strategies

Given the occupational nature of asbestosis, preventive strategies are of paramount importance. These include strict workplace safety regulations, the use of appropriate personal protective equipment, and the continuous monitoring and removal of asbestos-containing materials in the environment. Smoking cessation is also crucial, as smoking can significantly exacerbate the progression of asbestosis.

Prognosis and complications of asbestosis

The prognosis for individuals with asbestosis largely depends on the severity and progression of the disease, as well as any associated complications. Understanding potential complications and the overall outlook for patients is essential for informing treatment decisions and managing expectations.

Disease progression and survival rates

The severity of asbestosis is directly related to the duration and intensity of asbestos exposure. Generally, those with longer and more intense exposures have a poorer prognoses. The average life expectancy for individuals diagnosed with asbestosis is approximately 10 years, though this can vary depending on the individual case.

Respiratory complications

One of the most serious complications of asbestosis is the development of respiratory failure. As the scarring and stiffening of the lung tissue progresses, the lungs become less able to exchange oxygen and carbon dioxide, leading to hypoxaemia and life-threatening respiratory distress.

Malignant complications

Individuals with asbestosis also face an increased risk of developing certain types of cancer, particularly lung cancer and mesothelioma, a rare and aggressive form of cancer that affects the lining of the lungs or abdomen. The risk of these cancers is further exacerbated by smoking.

Cardiovascular complications

Asbestosis can also have effects on the cardiovascular system. The progressive fibrosis and remodelling of the pulmonary vasculature can lead to the development of pulmonary hypertension and right-sided heart failure, known as cor pulmonale, further compromising the patient’s overall health and prognosis.

The role of the interprofessional team

Effectively managing asbestosis requires the efforts of an interprofessional team of healthcare providers, including pulmonologists, radiologists, oncologists, thoracic surgeons, pharmacists, and nurses. This multidisciplinary approach ensures that the various aspects of the disease are addressed, and the patient’s needs are met.

Diagnostic and treatment coordination

The interprofessional team works together to coordinate the diagnostic process, ensuring that appropriate tests are ordered, and the results are interpreted accurately. They also collaborate to develop and implement a treatment plan, drawing upon their areas of expertise to provide the best possible care for the patient.

Patient education and support

Healthcare providers within the interprofessional team play a crucial role in educating patients and their families about the nature of asbestosis, the available treatment options, and the importance of preventive measures. This education and ongoing support can empower patients to actively participate in their care and make informed decisions about their health.

Continuous monitoring and coordination

The interprofessional team maintains close communication and coordination throughout the course of the patient’s care, ensuring that any changes in the disease status or the emergence of new complications are addressed. This collaborative approach helps to optimise patient outcomes and enhance the overall quality of life for individuals living with asbestosis.

Conclusion

Asbestosis is a complex and debilitating lung condition that requires understanding from both healthcare providers and the general public. As we continue to navigate the complexities of this condition, the hope is that advancements in research and healthcare delivery will pave the way for improved outcomes and a better future for those affected by asbestosis.

Sources

 

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Now Patient Data Security

Trusted and certified to keep your data safe.

Learn moreNow Patient Data Security
Now Patient Data Security

WHY WE BUILT NOWPATIENT

We are committed to helping everyone, everywhere live healthier lives

The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

About NowPatient

Your Questions Answered

For your peace of mind, we can answer your questions quickly

What does NowPatient do?

NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health.

Get started today and benefit from medication remindersGet Treated PrivatelyNHS online pharmacyGP appointment bookingRx savings cardDrug CouponsUS drug savings programshealth conditions informationgenetic testinghome test kitsBMI RisksType 2 Diabetes Riskspollen meterair quality monitor, and lots more!

Our service is operated by experienced medical professionals in the United States and the United Kingdom. You can view the online services that we provide by clicking Features.

UK users can safely and securely buy medicines online that treat a wide range of medical conditions. UK customers can also order NHS prescriptions online with the benefit of free tracked delivery.

US customers, regardless of insurance coverage, can enjoy huge savings on prescription medications using our various drug savings programs including drug coupons, savings card and manufacturer-sponsored patient assistance programs.

Where is NowPatient located?

NowPatient has offices in the United Kingdom and United States.

In the UK, we are located at:

NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA

In the US, we are located at:

NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX

How can I contact NowPatient?

To contact NowPatient, please use the contact form available on the Contact Us page.

Alternatively, if you need to speak to us, you can reach us on the following numbers:

UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977

Who owns NowPatient?

NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.

Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).

Can you tell me more about your NHS online pharmacy?

NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.

Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).

Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.

How do I make a complaint?

From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.

Can you tell me more about NowPatient’s prescribing services for treatments offered?

Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:

• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old

NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla.

Can you tell me more about NowPatient’s US services?

Our head of US services is Dr. Jamie Winn.

You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.

We do not provide any prescribing services or dispensing services in the United States.

Is NowPatient legit and can I trust information from NowPatient?

Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.

NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.

Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:

NowPatient Trustpilot

What are NowPatient’s opening hours?

Our office hours are:

UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST

Please note that we are closed at weekends.

In the event of a medical life-threatening emergency please call:

UK – 999
US – 911

In the event of a medical emergency which is not life-threatening please call:

UK – 111

Find more answers